Sanara MedTech Inc. Common Stock (SMTI) is a publicly traded Healthcare sector company. As of May 21, 2026, SMTI trades at $23.00 with a market cap of $200.60M and a P/E ratio of -5.28. SMTI moved +1.96% today. Year to date, SMTI is -2.38%; over the trailing twelve months it is -25.90%. Its 52-week range spans $16.05 to $39.08. Analyst consensus is buy with an average price target of $34.00. Rallies surfaces SMTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own SMTI include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sanara MedTech Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $23.00 |
| Market Cap | $200.60M |
| P/E Ratio | -5.28 |
| EPS | $-4.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.08 |
| 52-Week Low | $16.05 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $103.12M |
| Net Income | $-37.57M |
| Gross Margin | 92.71% |
2 analysts cover SMTI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $34.00.